Ldl Cholesterol

ATLANTA — In this Healio video exclusive, Erica S. Spatz, MD, MHS, discusses research into lipid disorders from the American College of Cardiology Scientific Session, examining results of the LIBerate-HR trial on LDL cholesterol levels.

ATLANTA — An investigational monthly PCSK9 inhibitor cut LDL cholesterol by more than 50% at 1 year among adults with CVD or with very high risk, in addition to background statin and ezetimibe therapy, researchers reported.

ATLANTA — New results from the TACTiC trial show the promise of technology to help individuals appropriately determine if they qualify for statin therapy without a prescription.

ATLANTA — For patients with atherosclerotic CVD, an inclisiran-first strategy was associated with greater lowering of LDL compared with the usual care, researchers reported at the American College of Cardiology Scientific Session.

Men with coronary artery disease who combined nitrates for chest pain with a PDE5 inhibitor for erectile dysfunction were at higher risk for death or major adverse cardiovascular events compared with taking nitrates alone, researchers said.

Elevated lipid levels were associated with worsening structural and functional cardiac damage in adolescents and young adults, though in the case of LDL, the relationship was partially mediated by elevated BP and fat mass, data show.